Jehn‐Hsiahn Yang

No ORCID on file · 13 papers in corpus · active 2000-2024

Study types

  • article 11

Condition tags

  • adenomyosis 9
  • endometriosis 6
  • dysmenorrhea 3
  • dyspareunia 1
article 2024
·doi:10.1097/ogx.0000000000001257

ABSTRACT Placenta accreta spectrum (PAS) is described as a partial or total lack of decidua with adherence or invasion of the placenta to the myometrium and is a major cause of postpartum hemorrhage and peripartum hysterectomy. The risk of …

2020
PloS one ·doi:10.1371/journal.pone.0240882

The optimal timing of frozen-thawed blastocyst transfer following hysteroscopic polypectomy is an important and unanswered clinical question. In this study, we conducted a retrospective survey of cases from an infertility center at an acade…

2019
BJOG : an international journal of obstetrics and gynaecology ·doi:10.1111/1471-0528.15410

Postpartum haemorrhage (PPH), especially resulting from placenta accreta spectrum (PAS), has become a worldwide concern in maternity care. We describe a novel method of uterine compression sutures (the 'Nausicaa' technique) as an alternativ…

article 2013
Clinical nuclear medicine ·doi:10.1097/rlu.0b013e318292f118

Abscess formation inside adenomyosis rarely occurred. A 49-year-old woman had adenomyosis for several years with the symptoms of menorrhagia and dysmenorrhea. She presented with fever of unknown etiology for 3 weeks. 67Ga SPECT/CT demonstra…

article 2010
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/s1028-4559(10)60034-4

OBJECTIVE: Insertion of the levonorgestrel-releasing intrauterine system Mirena is difficult in women with adenomyosis, and the device is often subsequently expelled. We used a novel insertion technique (Yang's method) to overcome this prob…

article 2009
article 2008
Fertility and sterility ·doi:10.1016/j.fertnstert.2008.05.090

ObjectiveTo investigate cell invasiveness and the production of matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 in endometrial stromal cells (ESCs) of adenomyosis.DesignProspective stud…

article 2007
Human Reproduction ·doi:10.1093/humrep/del493

BACKGROUND: The eutopic endometrium in a woman suffering from adenomyosis is known to be biologically different from that of healthy women. The aim of this study was to examine the apoptosis and proliferation of eutopic endometrium from wom…

article 2006
·doi:10.1586/17474108.1.1.111

Adenomyosis is a common gynecological disorder that is characterized by the presence of ectopic endometrial glands and stroma embedded within the myometrium with adjacent smooth muscle hyperplasia. Menorrhagia, dysmenorrhea, metrorrhagia an…

article 2006
Fertility and sterility ·doi:10.1016/j.fertnstert.2006.04.034

ObjectiveTo examine changes in local cytokine production in the eutopic endometrium of adenomyosis after treatment with medroxyprogesterone acetate (MPA) and danazol.DesignProspective cohort study.SettingTertiary university hospital.Patient…

article 2006
·doi:10.1007/s10815-006-9053-1
article 2004
Human Reproduction ·doi:10.1093/humrep/deh372

BACKGROUND: Increased expression of killer cell inhibitory receptors (KIRs) has been found on natural killer (NK) cells in peritoneal fluid in women with endometriosis. In this study, we tried to measure the expression of KIRs on NK and T c…

article 2000
Fertility and Sterility ·doi:10.1016/s0015-0282(00)01592-2

ObjectiveMalfunction of peritoneal natural killer cells (NK) may result in endometriosis. The present study was designed to determine whether the decrease in NK cytotoxicity occurs at early and advanced stages of endometriosis and is due to…